Appelbaum, Jacob S. http://orcid.org/0000-0002-4362-7773
Wei, Andrew H.
Mandrekar, Sumithra J.
Tiong, Ing S. http://orcid.org/0000-0001-7417-4343
Chua, Chong Chyn
Teh, Tse-Chieh
Fong, Chun Yew
Ting, Stephen B. http://orcid.org/0000-0001-7755-8326
Weber, Daniela
Benner, Axel
Hill, Hannah
Saadati, Maral
Yin, Jun
Stone, Richard M. http://orcid.org/0000-0002-7526-2633
Garcia-Manero, Guillermo http://orcid.org/0000-0002-3631-2482
Erba, Harry P.
Uy, Geoffrey L.
Marcucci, Guido http://orcid.org/0000-0002-3983-5908
Larson, Richard A. http://orcid.org/0000-0001-9168-3203
Thomas, Abin
Freeman, Sylvie D. http://orcid.org/0000-0003-1869-180X
Almuina, Nuria Marquez
Döhner, Konstanze
Thomas, Ian
Russel, Nigel H.
Döhner, Hartmut http://orcid.org/0000-0003-2116-5536
Othus, Megan http://orcid.org/0000-0001-8176-6371
Estey, Elihu H.
Walter, Roland B. http://orcid.org/0000-0002-9268-3341
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01-CA180819)
Article History
Received: 12 December 2023
Revised: 5 January 2024
Accepted: 8 January 2024
First Online: 23 January 2024
Competing interests
: MO: consulting fees from Merck and Biosights; Data Safety Monitoring Board Member for BMS, Glycomimetics, Grifols. HD: Advisory role for AbbVie, Agios, Amgen, Astellas, AstraZeneca, BERLIN-CHEMIE, Bristol Myers Squibb, Celgene, Gilead Sciences, Janssen, Jazz Pharmaceuticals, Novartis, Servier, Stemline, Syndax; research funding from AbbVie, Agios, Amgen, Astellas, Bristol Myers Squibb, Jazz Pharmaceuticals, Kronos-Bio, Novartis, Pfizer. RBW: laboratory research grants and/or clinical trial support from Aptevo, Celgene, ImmunoGen, Janssen, Jazz, Kite, Kura, and Pfizer; ownership interests in Amphivena; consultant to Abbvie, Adicet, Amphivena, BerGenBio, Bristol Myers Squibb, GlaxoSmithKline, ImmunoGen, Kura, and Orum. SJM: Consulting role: Flatiron Health; Harbinger Oncology, Inc; Leadership roles: NCI CTAC SCTWG, NCI SCTIC, Program Director for Alliance Statistics and Data Management Grant. RMS: Steering Committee: Abbvie; DSMC: Epizeyme, Takeda, Aptevo, Syntrix, ; Advisory board: BMS, CTI Biopharma, GSK, Hermavant, Ligand Pharma, Lava Therapeutics, Redona Therapeutics, Avencell, BerGen Bio, Cellularity, CTI Pharma, Kura Oncology, Rigel; Speaker, Actinium, Arog, Boston Pharmacueticals, Janssen, Syros: Curis Oncology, Dava Oncology, Jazz. CCC: Participation in advisory board meetings for AbbVie, Pfizer, Sumitomo Pharma Oncology; honoraria for speakers bureau for Bristol Myers Squibb, Astra Zeneca, AbbVie and Pfizer. AHW: has served on advisory boards for Novartis, Astra Zeneca, Astellas, GSK, Janssen, Jazz, Amgen, Roche, Pfizer, Abbvie, Servier, Gilead, BMS and Beigene; has consulted for Abbvie, Servier, Novartis, Shoreline, Aculeus, receives research funding to the Institution from Novartis, Abbvie, Servier, BMS, Janssen, Syndax, Astex, Astra Zeneca, Amgen; serves on speaker’s bureaus for Abbvie, Novartis, BMS, Servier, Astellas; AHW is an employee of the Walter and Eliza Hall Institute (WEHI). WEHI receives milestone and royalty payments related to the development of Venetoclax. Current and past employees of Walter and Eliza Hall Institute may be eligible for financial benefits related to these payments. AHW receives such a financial benefit. RAL: has acted as a consultant or advisor to AbbVie, Amgen, Ariad/Takeda, Astellas, Celgene/BMS, Curis, CVS/Caremark, Epizyme, Immunogen, Jazz Pharmaceuticals, Kling Biotherapeutics, MedPace, MorphoSys, Novartis, and Servier, and has received clinical research support to his institution from Astellas, Celgene, Cellectis, Daiichi Sankyo, Forty Seven/Gilead, Novartis, and Rafael Pharmaceuticals, and royalties from UpToDate. CYF: has received honoraria from Abbvie, Amgen, Beigene, Bristol-Myers Squibb, Jazz, Novartis, Pfizer and Servier; has acted as a consultant/advisor for Abbvie, Amgen, Astellas Pharma, Bristol-Myers Squibb, Jazz, Novartis, Pfizer and Servier; and has received research funding from Amgen, Astellas and Jazz. SDF: research funding from Jazz and BMS; Speakers Bureau with Jazz, Pfizer, and Novartis. NHR: Research Support and Advisory Role for Pfizer, Research Support from Jazz.